RightFit
RecruitingNot applicable

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 99 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study uses eye scans to track changes in diseases of the retina’s blood vessels over time. The retina is the light-sensing layer at the back of the eye. It compares adults with these diseases and healthy adults to better identify when disease gets worse or improves with standard treatment.

This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

    Who can't join

    • Anyone under age 18 or pregnant.
    • People with developmental delays, those unable to give informed consent, or those unable to follow study instructions or complete tests.
    • Scans that are blurred by movement or have a signal strength below 7.
    • A history of glaucoma, age-related macular degeneration, or any eye disease that greatly affects vision.
    • A history of proliferative diabetic retinopathy—an advanced form of diabetes-related eye disease.
    • A history of any inflammatory disease—a disease involving swelling and irritation.
    • A history of heart disease or thyroid disease.
    • Healthy comparison participants also cannot have a history of any type of diabetes or high blood pressure.

    Simplified for readability. The official criteria below are what the study team uses.

    Official eligibility criteria

    Exclusion Criteria: * Both subjects with diseases and controls: * Children (age\<18) * Pregnant females * Developmentally delayed subjects * Subjects unable to provide informed consent * Inability to cooperate with tests and study instructions * Images with motion artifact or signal strength \< 7 * History of glaucoma * History of age-related macular degeneration * History of any visually significant eye disease * History of proliferative diabetic retinopathy * History of any inflammatory disease * History of heart disease * History of thyroid disease. * Additional criteria for controls: * History of any type of Diabetes Mellitus * History of any type of Hypertension

    Study sites (1)

    MD